Renaissance Capital logo

Medical device maker Alphatec sets terms

May 8, 2006

Alphatec Holdings, a designer and manufacturer of products for the surgical treatment of spine disorders, plans to offer 9.3 million shares at a range of $13 to $15. Assuming the stock prices at the midpoint, the company will have an initial market capitalization of $450 million. Deutsche Bank, First Albany and RBC Capital Markets will underwrite the deal. Timing has yet to be disclosed.